These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6433243)

  • 1. Action of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal.
    Emrich HM; Sonderegger P; Mai N
    Neurosci Lett; 1984 Jun; 47(3):369-73. PubMed ID: 6433243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrinsic effects of sarmazenil on sleep propensity and performance level of sleep-deprived subjects.
    Nave R; Herer P; Lavie P
    Psychopharmacology (Berl); 1994 Jul; 115(3):366-70. PubMed ID: 7871077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability.
    O'Boyle C; Lambe R; Darragh A; Taffe W; Brick I; Kenny M
    Br J Anaesth; 1983 Apr; 55(4):349-56. PubMed ID: 6404290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.
    Gentil V; Tavares S; Gorenstein C; Bello C; Mathias L; Gronich G; Singer J
    Psychopharmacology (Berl); 1990; 100(1):54-9. PubMed ID: 2104987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly.
    Mamelak M; Csima A; Buck L; Price V
    J Clin Psychopharmacol; 1989 Aug; 9(4):260-7. PubMed ID: 2671059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.
    Darragh A; Lambe R; Kenny M; Brick I; Taaffe W; O'Boyle C
    Br J Clin Pharmacol; 1982 Nov; 14(5):677-82. PubMed ID: 6814472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-like effects of the benzodiazepine receptor antagonist RO 15-1788.
    Lavie P; Peled R; Wollman M; Zomer J; Tzischinsky O
    Neuropsychobiology; 1987; 17(1-2):72-6. PubMed ID: 2819767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation.
    Schöpf J; Laurian S; Le PK; Gaillard JM
    Pharmacopsychiatry; 1984 May; 17(3):79-83. PubMed ID: 6429677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of a benzodiazepine antagonist Ro 15-1788 in the presence of stable concentrations of midazolam.
    Lauven PM; Schwilden H; Stoeckel H; Greenblatt DJ
    Anesthesiology; 1985 Jul; 63(1):61-4. PubMed ID: 2861765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of slow-wave sleep by benzodiazepine antagonist Ro 15-1788.
    Ziegler G; Ludwig L; Fritz G
    Lancet; 1985 Aug; 2(8453):510. PubMed ID: 2863538
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.
    Higgitt A; Lader M; Fonagy P
    Psychopharmacology (Berl); 1986; 89(4):395-403. PubMed ID: 3092269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of the benzodiazepine antagonist flumazenil (Ro 15-1788) on the performance of healthy subjects during experimentally induced ethanol intoxication.
    Flückiger A; Hartmann D; Leishman B; Ziegler WH
    Eur J Clin Pharmacol; 1988; 34(3):273-6. PubMed ID: 3135194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the benzodiazepine antagonist Ro 15-1788 on flunitrazepam-induced sleep changes.
    Gaillard JM; Blois R
    Br J Clin Pharmacol; 1983 May; 15(5):529-36. PubMed ID: 6134542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans.
    Klotz U; Ziegler G; Ludwig L; Reimann IW
    J Clin Pharmacol; 1985 Sep; 25(6):400-6. PubMed ID: 2865275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
    Rouiller M; Forster A; Gemperle M
    Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiagabine is associated with sustained attention during sleep restriction: evidence for the value of slow-wave sleep enhancement?
    Walsh JK; Randazzo AC; Stone K; Eisenstein R; Feren SD; Kajy S; Dickey P; Roehrs T; Roth T; Schweitzer PK
    Sleep; 2006 Apr; 29(4):433-43. PubMed ID: 16676776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flumazenil-augmentation on microsleep and mood in depressed patients during partial sleep deprivation.
    Hemmeter U; Hatzinger M; Brand S; Holsboer-Trachsler E
    J Psychiatr Res; 2007 Nov; 41(10):876-84. PubMed ID: 16978648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of visual function in healthy subjects after administration of Ro 15-1788.
    Lupolover Y; Safran AB; Desangles D; de Weisse C; Meyer JJ; Bousquet A; Assimacopoulos A
    Eur J Clin Pharmacol; 1984; 27(4):505-7. PubMed ID: 6440793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of single oral doses of bromazepam, buspirone and clobazam on performance tasks and memory.
    Bourin M; Auget JL; Colombel MC; Larousse C
    Neuropsychobiology; 1989; 22(3):141-5. PubMed ID: 2577220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of the benzodiazepine antagonist Ro 15-1788 following anesthesia induced by flunitrazepam].
    Lauven PM; Ebeling BJ; Stoeckel H; Dierke-Dzierzon C
    Anasth Intensivther Notfallmed; 1986 Dec; 21(6):311-4. PubMed ID: 3101535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.